What is Parnax Lab Ltd (PARNAXLAB) share price return in the past 10 years?

Parnax Lab Ltd share price has appreciated 10% annually (CAGR) over the past ten years.

What is the share price of Parnax Lab Ltd (PARNAXLAB)?

Company share prices are keep on changing according to the market conditions. The current trading price of Parnax Lab Ltd (PARNAXLAB) on 14-Oct-2026 16:59:59 at 16:59 is 110.25.

What is the P/E ratio of Parnax Lab?

The latest standalone P/E ratio of Parnax Lab as of 14-Oct-2026 is 84.59.

What is the P/B ratio of Parnax Lab Ltd (PARNAXLAB)?

The latest standalone P/B ratio of Parnax Lab Ltd (PARNAXLAB) as of 14-Oct-2026 is 5.23.

What is the 52-week high and low of Parnax Lab Ltd (PARNAXLAB)?

The 52-week high of Parnax Lab Ltd (PARNAXLAB) is Rs. 182.00 and the 52-week low is Rs. 99.20.

Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.

Received from

Pending at the end of last month

Received

Resolved*

Total Pending #

Pending complaints >3months

Average Resolution time^ (in days)

Directly from Investors

SEBI (SCORES)

Other Sources (if any)

Grand Total

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.

Month

Carried forward from previous month

Received

Resolved*

Pending#

Jun, 2026

Jul, 2026

Aug, 2026

Grand Total

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Sr. No.

Fin. Year

Carried forward from previous year

Received

Resolved*

Pending#

2022-23

2023-24

2024-25

2025-26

Grand Total

Parnax Lab Ltd (PARNAXLAB)

Name: Parnax Lab Ltd (PARNAXLAB)
Brand: Parnax Lab

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506128 NSE: PARNAXLAB Pharmaceuticals & Drugs | Small Cap | Parnax Lab Share Price

₹110.25 -4.80 (-4.17%)

As on 14-Oct'26 16:59

Parnax Lab Ltd (PARNAXLAB)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506128 NSE: PARNAXLAB Pharmaceuticals & Drugs | Small Cap | Parnax Lab Share Price

₹110.25 -4.80 (-4.17%)

As on 14-Oct'26 16:59

Key Metrics

Valuation Multiples

Market Cap

₹127 Cr.

Current Price

₹110.3

52-Week Low / High

₹99 / 182

TTM EPS

₹7.8

TTM Sales

₹252 Cr.

Book Value per Share

₹83.2

P/E Ratio

14.19

Lower than its 5-year historical median

Industry PE

52.6

Price to Book (P/B)

1.33

Lower than its 5-year historical median

Price to Sales (P/S)

0.50

Lower than its 5-year historical median

EV/EBITDA

7.14

Lower than its 5-year historical median

Dividend Yield

Profitability Efficiency

Return on Equity (ROE)

13.24%

Outperforms industry median

Return on Capital Employed (ROCE)

13.79%

Outperforms industry median

Return on Assets (ROA)

5.65%

Operating Profit Margin

11%

Net Profit Margin

4.75%

Gross Profit Margin

10.2%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-5.56%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

1.79%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

2.25%

Asset Quality

Promoter Holding

72.30%

Pledged shares (%) of Promoter's holding (%)

9.41%

Reserves

₹84 Cr.

Equity

₹11.5 Cr.

Face Value

₹10

All Time Low / High

₹8.40 / 193.50

Parnax Lab stock performance

Key Ratios

Check Before You Invest

Quality

Somewhat Good

Check detailed performance

Valuation

Overvalued

Check Valuation charts

Price Trend

Weak

Check Price chart

Q.1 Is Parnax Lab Ltd a good quality company?

Parnax Lab Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Parnax Lab Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Parnax Lab Ltd vs industry peers?

Parnax Lab Ltd revenue CAGR is 22.51%, compared to the industry median CAGR of 0.00%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Parnax Lab Ltd?

Promoters hold 72.30% of the Parnax Lab Ltd, with 9.41% of their stake pledged, indicating low pledge risk.

Q.1 Stock return of Parnax Lab Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 10.5% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
ROCE % ⓘ	1.4%	-5.4%	2.9%	5%	-2.6%	7.8%	8.9%	12.5%	8.6%	3%	-
Value Creation Index ⓘ	-0.9	-1.4	-0.8	-0.6	-1.2	-0.4	-0.4	-0.1	-0.4	-0.8	-
Growth Parameters ⓘ
Sales ⓘ	5.3	5.8	6.5	7.7	2.4	7.2	7.5	7.4	7	6.6	7
Sales YoY Gr.	-	9.9%	11.9%	18.3%	-69.1%	201.7%	4.5%	-0.4%	-5.7%	-5.6%	-
Adj EPS ⓘ	-0.8	-1.7	-1	-2.4	-1.3	0.5	0.9	1.5	1.2	0.7	1.3
YoY Gr.	-	NA	NA	NA	NA	NA	89.8%	62.4%	-21.9%	-37.3%	-
BVPS (₹) ⓘ	12.9	10.2	9.2	6.9	5.5	11.1	16.9	18.4	19.6	20.4	21.1
Adj Net Profit ⓘ	-0.7	-1.4	-0.9	-2.1	-1.1	0.5	1.1	1.7	1.4	0.9	2
Cash Flow from Ops. ⓘ	3.7	0.6	1.7	2.2	0.5	-0.4	-0.3	0.1	0.3	-0.7	-
Debt/CF from Ops. ⓘ	3.3	19.4	6.7	5	24.2	-25.5	-3.8	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	2.6%	22.8%	-3.9%	-5.6%
Adj EPS ⓘ	NA	NA	-7.3%	-37.3%
BVPSⓘ	5.2%	29.8%	6.6%	3.9%
Share Price	10%	33.9%	3.3%	-14.6%

Key Financial Parameters ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
Return on Equity % ⓘ	-5.9	-14.5	-10.4	-30.4	-21.5	5.6	6.6	8.6	6.2	3.7	6.3
Op. Profit Mgn % ⓘ	0.1	6	1.7	7	-19.3	19.1	21.1	28.4	17.6	-24	-15.3
Net Profit Mgn % ⓘ	-12.6	-24.6	-13.2	-27	-47.7	6.8	14.3	23.3	19.2	12.8	20.9
Debt to Equity ⓘ	1.1	1.4	1.4	1.9	2.4	0.8	0.1	0	0	0	-
Working Cap Days ⓘ	527	461	485	257	389	148	222	314	442	555	1,484
Cash Conv. Cycle ⓘ	355	178	122	61	88	19	49	37	8	13	1,375

Valuation of Parnax Lab - Consolidated

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

9.41

* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Sales	95	105	109	95	90	163	168	189	188	249
Operating Expenses ⓘ +	82	96	99	89	80	140	145	165	161	221
Manufacturing Costs	18	17	19	21	18	25	27	30	31	35
Material Costs	50	55	53	45	42	90	89	103	96	147
Employee Cost	9	12	13	14	14	17	20	24	24	27
Other Costs ⓘ	6	12	14	8	6	8	9	8	10	13
Operating Profit ⓘ	12	10	10	6	10	23	23	24	27	27
Operating Profit Margin (%)	13.1%	9.2%	9.4%	6.7%	11.0%	14.1%	13.7%	12.5%	14.3%	11.0%
Other Income ⓘ +	1	1	2	1	0	0	1	1	2	4
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	-1
Interest ⓘ	5	4	4	5	5	5	5	5	5	6
Depreciation ⓘ	4	4	4	4	5	6	7	7	7	8
Profit Before Tax ⓘ	5	3	5	-2	-0	12	12	12	16	16
Tax ⓘ	1	2	1	1	0	4	4	2	4	4
Profit After Tax	4	1	3	-3	-0	8	9	10	12	12
PAT Margin (%)	3.9%	1.0%	3.0%	-3.1%	-0.4%	5.1%	5.2%	5.1%	6.2%	4.8%
Adjusted EPS (₹)	4.3	1.2	3.9	-3.4	-0.4	8.4	7.5	8.4	10.0	10.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Equity and Liabilities
Shareholders Fund +	31	33	36	33	33	46	62	72	83	95
Share Capital ⓘ	8.50	8.50	8.50	8.50	8.50	9.81	11.49	11.49	11.49	11.49
Reserves ⓘ	23	24	27	24	24	37	51	60	72	84
Debt +	33	32	37	47	50	60	45	64	54	69
Long Term Debt	17	17	22	19	14	17	12	21	18	22
Short Term Debt	16	15	16	28	36	43	33	43	36	48
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	8	8	7	11	6	22	15	24	21	32
Others Liabilities ⓘ	14	15	14	16	17	25	23	31	31	31
Total Liabilities ⓘ	86	87	95	107	106	153	145	190	190	228
Fixed Assets
Net Fixed Assets ⓘ +	47	44	51	58	60	72	77	89	88	115
Gross Block	51	50	62	73	79	97	108	127	129	161
Accumulated Depreciation	4	7	11	15	20	25	31	37	40	46
CWIP ⓘ	0	0	0	3	5	3	2	21	29	11
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	8	8	8	11	11	20	22	30	26	36
Trade Receivables	19	19	19	23	17	38	28	33	31	38
Cash Equivalents	1	2	1	1	1	6	3	2	3	2
Others Assets ⓘ	10	15	15	11	13	14	13	16	13	25
Total Assets ⓘ	86	87	95	107	106	153	145	190	190	228

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Cash Flow From Operating Activity ⓘ +	16	13	9	9	6	9	21	16	32	8
PBT ⓘ	5	3	5	-2	-0	12	12	12	16	16
Adjustment ⓘ	9	10	8	9	10	11	12	12	13	15
Changes in Working Capital ⓘ	4	1	-2	3	-3	-15	-0	-5	7	-19
Tax Paid ⓘ	-1	-1	-1	-1	-1	-0	-3	-3	-3	-4
Cash Flow From Investing Activity ⓘ +	-10	-5	-11	-13	-7	-16	-10	-32	-16	-16
Capex	-11	-5	-11	-10	-4	-18	-11	-14	-7	-35
Net Investments	1	-0	0	-0	-0	-0	-0	0	-1	0
Others ⓘ	0	0	0	-3	-2	2	1	-18	-9	18
Cash Flow From Financing Activity ⓘ +	-5	-7	1	5	0	12	-14	15	-16	8
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	3	-5	9	-3	4
Interest Paid ⓘ	-4	-4	-3	-5	-5	-5	-5	-5	-5	-6
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-1	-3	5	10	5	14	-4	11	-7	10
Net Cash Flow ⓘ	0	1	-1	0	-0	4	-3	-1	0	-0

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Ratios
ROE (%)	12.51	3.31	9.69	-8.51	-1.11	20.93	15.91	14.39	14.92	13.24
ROCE (%)	13.73	10.49	11.59	3.27	5.83	17.34	15.2	13.61	14.71	13.79
Asset Turnover Ratio	1.15	1.22	1.2	0.94	0.84	1.26	1.12	1.13	0.99	1.19
PAT to CFO Conversion(x)	4	13	3	N/A	N/A	1.13	2.33	1.6	2.67	0.67
Working Capital Days
Receivable Days	73.30	64.60	63.50	80.90	80.60	61.30	71.80	58.50	61.60	50.40
Inventory Days	28.10	27	27.10	37.60	44.50	34.40	45.30	49.90	54.10	45.50
Payable Days	39.30	51	51.70	73	74.70	57.60	75.70	68.20	85.60	66.50

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Parnax Lab Ltd FAQs

The current trading price of Parnax Lab on 14-Oct-2026 16:59 is ₹110.2.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 13-Oct-2026 the market cap of Parnax Lab stood at ₹126.8 Cr

The latest P/E ratio of Parnax Lab as of 13-Oct-2026 is 84.59.

The latest P/B ratio of Parnax Lab as of 13-Oct-2026 is 5.23.

The 52-week high of Parnax Lab is ₹182.0 and the 52-week low is ₹99.20.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Parnax Lab is ₹7.22 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Parnax Lab Ltd is a average quality company.

The key valuation ratios of Parnax Lab Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Parnax Lab Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Parnax Lab Ltd

Parnax Lab, earlier known as Krishnadeep Trade and Investments, incorporated in the year 1982, engages in investing and financial businesses in India. The company is based in Mumbai, India. In 2012 the company has changed its name from Krishna Deep Trade & Investments Ltd. to Parnax Lab Ltd. "

In 2009, Krishna Deep Trade and Investments appointed Rasik Chaturvedi and Dilip Pimparkar as additional directors of the company with effect from February 16, 2009. Further, Rasik Chaturvedi and Dilip Pimparkar have also been inducted on the Audit Committee of the Company.

The registered office of the company is 136, Greet Western Building, Nagindas Master Road Extension, Fort Mumbai, Maharashtra-400001.

You have 47 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Parnax Lab Ltd (PARNAXLAB)

Parnax Lab Ltd (PARNAXLAB)

Parnax Lab stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Valuation of Parnax Lab - Consolidated

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Financials

Equity and Liabilities

Fixed Assets

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Parnax Lab Ltd FAQs

About Parnax Lab Ltd

Current Complaints

^ Average Resolution time is the sum total of time taken to resolve each complaint in days, in the current month divided by total number of complaints resolved in the current month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Parnax Lab Ltd (PARNAXLAB)

Parnax Lab Ltd (PARNAXLAB)

Parnax Lab stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Valuation of Parnax Lab - Consolidated

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Financials

Equity and Liabilities

Fixed Assets

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Parnax Lab Ltd FAQs

What is the share price of Parnax Lab?

What is the market cap of Parnax Lab?

What is the P/E ratio of Parnax Lab?

What is the P/B ratio of Parnax Lab?

What is the 52-week high and low of Parnax Lab?

What is the TTM revenue of Parnax Lab?

Is Parnax Lab Ltd a good quality company?

Is Parnax Lab Ltd undervalued or overvalued?

Is Parnax Lab Ltd a good buy now?

About Parnax Lab Ltd